Xu F - Search Results

1

SPARC expression and prognostic value in non-small cell lung cancer.

Huang Y, Zhang J, Zhao YY, Jiang W, Xue C, Xu F, Zhao HY, Zhang Y, Zhao LP, Hu ZH, Yao ZW, Liu QY, Zhang L. Huang Y, et al. Among authors: xu f. Chin J Cancer. 2012 Nov;31(11):541-8. doi: 10.5732/cjc.012.10212. Epub 2012 Oct 10. Chin J Cancer. 2012. PMID: 23114088 Free PMC article.

2

[Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in treatment of advanced non-small cell lung cancer (NSCLC)].

Zhang L, Zhang Y, Li N, Xu F, Pan ZK, Guan ZZ. Zhang L, et al. Among authors: xu f. Ai Zheng. 2004 Nov;23(11 Suppl):1455-8. Ai Zheng. 2004. PMID: 15566656 Clinical Trial. Chinese.

3

[Epidermal growth factor receptor mutation in Chinese patients with non-small cell lung cancer].

Pan ZK, Zhang L, Zhang X, Wang X, Li N, Xu F, Chang JH, Guan ZZ. Pan ZK, et al. Among authors: xu f. Ai Zheng. 2005 Aug;24(8):919-23. Ai Zheng. 2005. PMID: 16086866 Chinese.

4

[Clinical significance of survivin expression in peripheral T-cell lymphoma].

Xiang XJ, He YJ, Li YH, Huang H, Xu F. Xiang XJ, et al. Among authors: xu f. Ai Zheng. 2006 Jun;25(6):758-61. Ai Zheng. 2006. PMID: 16764776 Chinese.

5

[High-dose induction therapy followed by maintenance with recombinant human erythropoietin for 30 patients with tumor-related anemia].

Xu F, Zhang L, Xiang XJ, Wang ZQ, Zhou ZM, Wang SY. Xu F, et al. Ai Zheng. 2006 Sep;25(9):1120-2. Ai Zheng. 2006. PMID: 16965653 Chinese.

6

[Efficacy of gefitinib on advanced non-small cell lung cancer in expanded access program (EAP)].

Zhang Y, Zhang L, Xu F, Wang ZQ, Zhao HY, Guan ZZ, Xu GC, Pan ZK. Zhang Y, et al. Among authors: xu f, xu gc. Ai Zheng. 2006 Dec;25(12):1561-4. Ai Zheng. 2006. PMID: 17166387 Chinese.

7

Phase II clinical study of gemcitabine in the treatment of patients with advanced nasopharyngeal carcinoma after the failure of platinum-based chemotherapy.

Zhang L, Zhang Y, Huang PY, Xu F, Peng PJ, Guan ZZ. Zhang L, et al. Among authors: xu f. Cancer Chemother Pharmacol. 2008 Jan;61(1):33-8. doi: 10.1007/s00280-007-0441-8. Epub 2007 Mar 20. Cancer Chemother Pharmacol. 2008. PMID: 17909810 Clinical Trial.

8

[Responses of 109 adult soft tissue sarcoma patients to chemotherapy].

Qiu MZ, Xu F, Wang SS, Luo HY, Wang F, Li FH, Sun XF, Xu GC, Lin TY, Huang HQ, Jiang WQ, Guan ZZ, Xu RH. Qiu MZ, et al. Among authors: xu rh, xu f, xu gc. Ai Zheng. 2007 Dec;26(12):1344-9. Ai Zheng. 2007. PMID: 18076798 Free article. Chinese.

9

[Analysis of the efficacy and safety of gefitinib in the treatment of recurrent advanced non-small cell lung cancer in an expanded access program (EAP)].

Huang H, Zhang Y, Zhao HY, Wang ZQ, Xu F, Xu GC, Zhang L, Guan ZZ. Huang H, et al. Among authors: xu f, xu gc. Zhonghua Zhong Liu Za Zhi. 2009 Feb;31(2):148-51. Zhonghua Zhong Liu Za Zhi. 2009. PMID: 19538895 Chinese.

10

[K-RAS gene mutations in patients with non-small cell lung cancer].

Zhang Y, Pan Z, Zhang X, Xu F, Zhang L. Zhang Y, et al. Among authors: xu f. Zhongguo Fei Ai Za Zhi. 2010 Jun;13(6):602-6. doi: 10.3779/j.issn.1009-3419.2010.06.007. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20681447 Free PMC article. Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15,119 results

Search Page

Filters